GIPR and atherosclerosis: Chronic administration of GIP remarkably suppressed the progression of atherosclerosis in STZ-induced diabetic Apoe−/− mice and suppressed macrophage foam cell formation in both diabetic Apoe−/− mice and diabetic db/db mice, even though GIPR expression in macrophages was mildly down-regulated in the diabetic state.